Deferred Tax Assets, Valuation Allowance of Entera Bio Ltd. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Entera Bio Ltd. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Entera Bio Ltd. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $20,873,000, a 7.2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Entera Bio Ltd. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $20,873,000 +$1,402,000 +7.2% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $19,471,000 +$1,826,000 +10% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $17,645,000 +$2,620,000 +17% 31 Dec 2022 10-K 28 Mar 2025 2024 FY
Q4 2021 $15,025,000 +$2,605,000 +21% 31 Dec 2021 10-K 08 Mar 2024 2023 FY
Q4 2020 $12,420,000 +$2,702,000 +28% 31 Dec 2020 10-K 31 Mar 2023 2022 FY
Q4 2019 $9,718,000 31 Dec 2019 10-K 08 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.